Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Abaxis (ABAX)

Add to Watchlists
Create an Alert
39.31 +0.10  +0.26% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
ABAX Price Chart
View All Events

ABAX Events

Date Type Description
Apr 24 Misc Q4 2014 Abaxis, Inc. Earnings Conference Call
Apr 24 Earnings Q4 2014 Abaxis, Inc. Earnings Results. Estimate: 0.20.
Feb 27 Misc Abaxis, Inc. To Present at the Raymond James 35th Annual Institutional Investors Conference
Jan 30 Misc Abaxis Q3 2014 Earnigns Conference Call
Jan 30 Earnings Abaxis to Report Third Quarter Fiscal Year 2014 Financial Results Thursday, January 30, 2014. Estimate: 0.22.
Oct 22 Misc Abaxis Announces Second Quarter Fiscal Year 2014 Financial Call
Oct 22 Earnings Abaxis to Report Second Quarter Fiscal Year 2014 Financial Results Tuesday, October 22, 2013. Estimate: 0.20.
Jul 25 Misc First Quarter Earnings Conference Call
Jul 25 Earnings Abaxis to Report First Quarter Fiscal Year 2014 Financial Results Thursday, July 25, 2013. Estimate: 0.23.
Apr 25 Misc Abaxis to Report Fourth Quarter and Fiscal Year 2013 Financial Results Thursday, April 25, 2013
View All Performance Charts

ABAX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Abaxis is down 12.02% over the last year vs S&P 500 Total Return up 21.33%, SurModics down 15.95%, and Alere up 40.42%.

Get Quote for

PDF Report for ABAX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ABAX Pro Report PDF

Portfolio Strategies Featuring ABAX

Did Abaxis make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ABAX Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: California
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: March 31, 2015
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in veterinary or human patient-care setting to provide blood constituent measurements for clinicians worldwide. The company offers point-of-care blood chemistry analyzer to perform 14 tests on human patients and 13 tests on veterinary patients. It markets the blood analysis system under the Piccolo Xpress and Piccolo Classic names in the medical market; and under the VetScan VS2 and VetScan Classic names in the veterinary market. The company also provides reagent discs to handle various technical steps of blood chemistry testing; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments for veterinary applications. In addition, its products include VetScan VSpro, which assists in the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, evaluation of disseminated intravascular coagulation, hepatic disease, monitoring therapy, and the progression of disease states. Further, the company offers VetScan VSpro fibrinogen test to provide in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and VetScan i-STAT 1 that delivers blood gas, electrolyte, basic blood chemistry, and hematology results. Additionally, its products comprise VetScan Canine heartworm rapid test to detect dirofilaria immitis in canine whole blood, serum, or plasma; VetScan Canine parvovirus rapid test kit to detect canine parvovirus antigen in feces; VetScan Giardia rapid test to detect giardiasis, a gastrointestinal infection caused by the protozoan parasite Giardia; and Orbos Discrete Lyophilization process that involves in flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. Abaxis sells its products through direct sales force and independent distributors. The company was founded in 1989 and is headquartered in Union City, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ABAX 39.31 +0.10 +0.26% 874.45M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.